Your search returned 719 results.

Results
	521.	Prospective exosome-focused translational research for afatinib study of non-small cell lung cancer patients expressing EGFR (EXTRA study). [electronic resource] by Okuma, Yusuke Morikawa, Kei Tanaka, Hisashi Yokoyama, Takuma Itani, Hidetoshi Horiuchi, Kazuya Nakagawa, Hideyuki Takahashi, Nobumasa Bessho, Akihiro Soejima, Kenzo Kishi, Kazuma Togashi, Akira Kanai, Yae Ueda, Koji Horimoto, Katsuhisa Matsutani, Noriyuki Seki, Nobuhiko Producer: 20200207 In: Thoracic cancer vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	522.	Phase I Study Evaluating the Combination of Afatinib with Carboplatin and Pemetrexed After First-line EGFR-TKIs. [electronic resource] by Watanabe, Satoshi Yamaguchi, O U Masumoto, A I Maeno, Yuri Kawashima, Yosuke Ishimoto, Osamu Sugawara, Shunichi Yoshizawa, Hirohisa Kikuchi, Toshiaki Nukiwa, Toshihiro Kobayashi, Kunihiko Producer: 20180806 In: Anticancer research vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	523.	Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. [electronic resource] by Vengoji, Raghupathy Macha, Muzafar A Nimmakayala, Rama Krishna Rachagani, Satyanarayana Siddiqui, Jawed A Mallya, Kavita Gorantla, Santhi Jain, Maneesh Ponnusamy, Moorthy P Batra, Surinder K Shonka, Nicole Producer: 20191202 In: Journal of experimental & clinical cancer research : CR vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	524.	Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer. [electronic resource] by Shin, Dong Hoon Jo, Jeong Yeon Han, Ji-Youn Producer: 20190903 In: Molecular cancer therapeutics vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	525.	Glycolysis inhibition sensitizes non-small cell lung cancer with T790M mutation to irreversible EGFR inhibitors via translational suppression of Mcl-1 by AMPK activation. [electronic resource] by Kim, Sun Mi Yun, Mi Ran Hong, Yun Kyoung Solca, Flavio Kim, Joo-Hang Kim, Hyun-Jung Cho, Byoung Chul Producer: 20140519 In: Molecular cancer therapeutics vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	526.	Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response. [electronic resource] by Zhang, Xu Maity, Tapan Kashyap, Manoj K Bansal, Mukesh Venugopalan, Abhilash Singh, Sahib Awasthi, Shivangi Marimuthu, Arivusudar Charles Jacob, Harrys Kishore Belkina, Natalya Pitts, Stephanie Cultraro, Constance M Gao, Shaojian Kirkali, Guldal Biswas, Romi Chaerkady, Raghothama Califano, Andrea Pandey, Akhilesh Guha, Udayan Producer: 20180115 In: Molecular & cellular proteomics : MCP vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	527.	Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC). [electronic resource] by Codony-Servat, Carles Codony-Servat, Jordi Karachaliou, Niki Molina, Miguel Angel Chaib, Imane Ramirez, Jose Luis de Los Llanos Gil, Maria Solca, Flavio Bivona, Trever G Rosell, Rafael Producer: 20180423 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	528.	Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer. [electronic resource] by Tanaka, Hisashi Taima, Kageaki Itoga, Masamichi Ishioka, Yoshiko Baba, Keisuke Shiratori, Toshihiro Sakamoto, Hiroaki Tsuchiya, Junichiro Nakagawa, Hideyuki Hasegawa, Yukihiro Yasugahira, Hideo Okudera, Koichi Takanashi, Shingo Tasaka, Sadatomo Producer: 20191115 In: Medical oncology (Northwood, London, England) vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	529.	Boswellic acid has anti-inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells. [electronic resource] by Barbarisi, Manlio Barbarisi, Alfonso De Sena, Gabriele Armenia, Emilia Aurilio, Caterina Libutti, Michele Iaffaioli, Rosario Vincenzo Botti, Gerardo Maurea, Nicola Quagliariello, Vincenzo Producer: 20191120 In: Phytotherapy research : PTR vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	530.	Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials. [electronic resource] by Yang, James Chih-Hsin Wu, Yi-Long Schuler, Martin Sebastian, Martin Popat, Sanjay Yamamoto, Nobuyuki Zhou, Caicun Hu, Cheng-Ping O'Byrne, Kenneth Feng, Jifeng Lu, Shun Huang, Yunchao Geater, Sarayut L Lee, Kye Young Tsai, Chun-Ming Gorbunova, Vera Hirsh, Vera Bennouna, Jaafar Orlov, Sergey Mok, Tony Boyer, Michael Su, Wu-Chou Lee, Ki Hyeong Kato, Terufumi Massey, Dan Shahidi, Mehdi Zazulina, Victoria Sequist, Lecia V Producer: 20150331 In: The Lancet. Oncology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	531.	Evaluation of the VeriStrat [electronic resource] by Gadgeel, Shirish Goss, Glenwood Soria, Jean-Charles Felip, Enriqueta Georgoulias, Vassilis Lu, Shun Cobo, Manuel Syrigos, Konstantinos Lee, Ki Hyeong Göker, Erdem Guclu, Salih Z Isla, Dolores Morabito, Alessandro Dupuis, Nicholas Bühnemann, Claudia Krämer, Nicole Solca, Flavio Ehrnrooth, Eva Ardizzoni, Andrea Producer: 20180309 In: Lung cancer (Amsterdam, Netherlands) vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	532.	Association Between EGFR T790M Status and Progression Patterns During Initial EGFR-TKI Treatment in Patients Harboring EGFR Mutation. [electronic resource] by Oya, Yuko Yoshida, Tatsuya Kuroda, Hiroaki Shimizu, Junichi Horio, Yoshitsugu Sakao, Yukinori Inaba, Yoshitaka Hida, Toyoaki Yatabe, Yasushi Producer: 20180619 In: Clinical lung cancer vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	533.	HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib. [electronic resource] by Wang, Y Jiang, T Qin, Z Jiang, J Wang, Q Yang, S Rivard, C Gao, G Ng, T L Tu, M M Yu, H Ji, H Zhou, C Ren, S Zhang, J Bunn, P Doebele, R C Camidge, D R Hirsch, F R Producer: 20200324 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	534.	Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report. [electronic resource] by Liu, Jing Jin, Bo Su, Hang Qu, Xiujuan Liu, Yunpeng Producer: 20191212 In: BMC cancer vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	535.	Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy. [electronic resource] by Dal Maso, Alessandro Lorenzi, Martina Roca, Elisa Pilotto, Sara Macerelli, Marianna Polo, Valentina Cecere, Fabiana Letizia Del Conte, Alessandro Nardo, Giorgia Buoro, Vanessa Scattolin, Daniela Monteverdi, Sara Urso, Loredana Zulato, Elisabetta Frega, Stefano Bonanno, Laura Indraccolo, Stefano Calabrese, Fiorella Conte, PierFranco Pasello, Giulia Producer: 20210401 In: Clinical lung cancer vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	536.	Association of Genetic Polymorphisms With Afatinib-induced Diarrhoea. [electronic resource] by Sogawa, Rintaro Nakashima, Chiho Nakamura, Tomomi Takeuchi, Koji Kimura, Sakiko Komiya, Kazutoshi Narisawa, Yutaka Kimura, Shinya Sueoka-Aragane, Naoko Producer: 20210212 In: In vivo (Athens, Greece) vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	537.	[Is chemotherapy still an option in oncogene-addicted non-small cell lung cancer? No]. [electronic resource] by Girard, Nicolas Producer: 20150904 In: Bulletin du cancer vol. 102 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	538.	New therapy targets resistant non-small-cell lung cancers. [electronic resource] by Jenks, Susan Producer: 20150219 In: Journal of the National Cancer Institute vol. 106 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	539.	Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O-desmethyl metabolites of erlotinib and gefitinib in human plasma. [electronic resource] by Sparidans, Rolf W Rosing, Hilde Rood, Johannes J M Schellens, Jan H M Beijnen, Jos H Producer: 20170217 In: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences vol. 1033-1034 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	540.	Blocking autophagy improves the anti-tumor activity of afatinib in lung adenocarcinoma with activating EGFR mutations in vitro and in vivo. [electronic resource] by Hu, Xiangxiang Shi, Si Wang, Huan Yu, Xiaochen Wang, Qian Jiang, Shanshan Ju, Dianwen Ye, Li Feng, Meiqing Producer: 20190110 In: Scientific reports vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 719 results.